Main, New Mountain, Marlin Equity target patient engagement tech; Specialty pharmacy, mental health needs drive Flexpoint’s sale of ArtesRx

Published on August 28, 2026

New software, including agentic AI applications, are fueling provider adoption of patient engagement technology, and PE dealmakers see opportunities to scale these capabilities further; exploring Flexpoint Ford's sale of ArtesRx, a behavioral health pharmacy, to Linden Capital Partners.

The post Main, New Mountain, Marlin Equity target patient engagement tech; Specialty pharmacy, mental health needs drive Flexpoint’s sale of ArtesRx appeared first on PE Hub.

Continue reading on website
Other news

So, where exactly does the US energy transition stand?

August 28, 2026
This analysis and news roundup come from the Canary Media Weekly newsletter. Sign up to get it every Friday. Glass half-empty or glass half-full? The classic question is now gripping the policy wonks who are trying to measure the damage President Donald Trump has inflicted on the U.S. energy transition — and to…

Europe is building a giant pipeline of social innovation. Why aren’t impact investors paying attention?

August 28, 2026
Europe is sitting on one of the biggest public pipelines of social innovation in the world, and most impact investors barely talk about ...The post Europe is building a giant pipeline of social innovation. Why aren’t impact investors paying attention? appeared first on ImpactAlpha.